We continue to receive questions regarding the future of the 340B drug discount program (“340B Program”) now that its mid-term longevity is no longer in doubt. These include whether Congress will continue to focus on limiting the 340B Program’s scope as well as what effect, if any, broader efforts to reduce drug costs might... READ MORE
340B Moving Forward: Legislative and Executive Branch 340B Priorities for 2019-2020
Posted on April 19, 2019 in Health Law News
Published by: Hall Render
